Molecular Medical Parasitology
35%
off

Molecular Medical Parasitology

Free delivery worldwide

Available. Dispatched from the UK in 1 business day
When will my order arrive?

Description

A valuable, new source, Molecular Medical Parasitology is the only text of its kind -- one that applies broad concepts and current scientific advances from both molecular biology and biochemistry to the study of parasitic organisms. An internationally renowned team of scientists and physicians places parasites in their broad biological contexts while still emphasizing the specifics that differentiate these organisms. Not only will researchers and faculty in parasitology find this an indispensable guide, physicians will benefit from the thorough coverage molecular biology and biochemistry's current influences on treatment and management of parasitic diseases.
show more

Product details

  • Hardback | 488 pages
  • 206 x 262 x 32mm | 1,401.59g
  • Academic Press Inc
  • San Diego, United States
  • English
  • Approx. 100 illustrations; Illustrations, unspecified
  • 0124733468
  • 9780124733466

Review quote

"...a valuable addition to the bookshelves of persons interested in molecular parasitology."
-CID (2003)
"...this book forms an important resource for graduate and advanced studies on parasitology."
-E-STREAMS (2003)
show more

Table of contents

Contents include:
- RNA editing and processing
- Genomics
- Post-transcriptional gene regulation
- Genetic approaches to analysis of virulence
- Protozoa and Helminth energy metabolism
- Trypanosomatid surface carbohydrates
- Plastids, mitochondria and hydrogenosomes
- Neurotransmitters
- Drug resistance in parasites
- Medical implications of molecular parasitology
show more

About Richard W. Komuniecki

Dr. J. J. Marr has held positions in academic medicine and biochemistry; as Director of Divisions of Infectious Diseases; Vice Chairman, Department of Medicine; and Professor of Medicine, Biochemistry and Microbiology at Washington University, St. Louis University and the University of Colorado. Subsequently, he was Senior Vice Presidnt for Drug Discovery at Searle Pharmaceuticals, acted as a consultant to the National Institutes of Health and the World Health Organization, and now holds the position of Vice President for Research and Development/Chief Scientific Officer, Ribozyme Pharmaceuticals, Inc.
show more